A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas
about
Clinical implications of enteroadherent Escherichia coliCrystal structure of enterotoxigenic Escherichia coli colonization factor CS6 reveals a novel type of functional assemblyDesigning vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli.Novel antigens for enterotoxigenic Escherichia coli vaccinesRecent advances in understanding enteric pathogenic Escherichia coli.Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli.Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.Combination vaccines against diarrheal diseases.Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model.A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles.Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization.Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA.Highlights of the 8th International Conference on Vaccines for Enteric Diseases: the Scottish Encounter To Defeat Diarrheal DiseasesVaccines for enteric diseases: a meeting summary.Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development.Enterotoxigenic Escherichia coli blood group A interactions intensify diarrheal severity.Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.
P2860
Q26865925-185EC74A-E023-4DA5-8470-1563B1F1B094Q27682738-6E0661BC-38FD-4854-A0A9-10565AEBA610Q33813634-69B7A6C1-4886-4F01-A834-6576DA2824D5Q34349166-D40C7C2E-DBAC-494C-9252-B1EC636A0530Q34375210-1C0DEEAD-9A7D-4C06-ABE8-52E781493935Q35023488-36D4887F-724D-4463-A089-04803C07A301Q35213355-639D04BC-E673-448C-8D34-E98BAF0BA4CBQ35896237-680CDE58-48F3-4758-91D7-0E525D98C063Q35920317-518C9366-9B0F-444B-A7E8-1F65A9F7BE66Q35935738-4598C6B6-C4E2-4270-827F-7391CBF3A5E6Q35998767-A0AF8F2F-7729-411F-83A8-41AA9FD51AF2Q36505159-FF9D290C-49ED-45C3-97A9-2AF210B80F9AQ37545078-BCB592ED-CBD2-4517-AE67-99DB084832FDQ38032878-E04F6AB1-A0DE-4EAB-906E-049CA8415EEAQ38908041-98651B6D-31B8-46A4-98A5-B588CFA30BABQ39657777-3A031092-74D7-459E-BB52-2D51E09AFB27Q40192692-CEE00270-6B14-4DB6-829F-0C9D07A567B2Q40375701-45F7F163-F9A4-4F0E-85AA-D69EA826E442Q41715897-6479289C-F432-4568-AF61-B08BE1EC8555Q42554197-00648353-92CB-4C39-B973-04755039BC53Q48008673-A25555F3-476C-4C86-8C8B-7866C5290A48Q53696162-D7E50E8B-3666-4F68-837B-283013D9BE25Q54201990-CB034901-EB4B-4B11-95C8-E0342BE72683Q55322314-DF87842A-F5B2-4C5C-AF10-F64B80B49C86
P2860
A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A combination vaccine consisti ...... o-controlled double-blind phas
@ast
A combination vaccine consisti ...... o-controlled double-blind phas
@en
type
label
A combination vaccine consisti ...... o-controlled double-blind phas
@ast
A combination vaccine consisti ...... o-controlled double-blind phas
@en
prefLabel
A combination vaccine consisti ...... o-controlled double-blind phas
@ast
A combination vaccine consisti ...... o-controlled double-blind phas
@en
P2093
P2860
P356
P1476
A combination vaccine consisti ...... o-controlled double-blind phas
@en
P2093
A Louis Bourgeois
Andrea Feller
Barbara DeNearing
Charlotte Buchwaldt
Clayton Harro
Michael J Darsley
Subhra Chakraborty
P2860
P304
P356
10.1128/CVI.05342-11
P577
2011-10-12T00:00:00Z